Halozyme Therapeutics, Inc.
HALO
Revenue
298.01M
▲7.92M▲2.73%
3 Months ChangeAssets
2.06B
▼-54.55M▼-2.58%
3 Months ChangeLiabilities
1.70B
▲34.33M▲2.06%
3 Months ChangeFree Cash Flow
125.88M
▲50.30M▲66.54%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001159036-24-000050
2024-10-31
Form 8-K
ID: 0001159036-24-000049
2024-08-06
Form 10-Q
ID: 0001159036-24-000044
2024-08-06
Form 8-K
ID: 0001159036-24-000043
2024-05-07
Form 10-Q
ID: 0001159036-24-000037
2024-05-07
Form 8-K
ID: 0001159036-24-000036
2024-04-26
Form 8-K
ID: 0001159036-24-000031
2024-02-20
Form 8-K
ID: 0001159036-24-000007
2024-01-17
Form 8-K
ID: 0001159036-24-000003
2023-11-06
Form 10-Q
ID: 0001159036-23-000057